XELLSMART
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
XELLSMART
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2021-01-01
Address:
Minhang, Shanghai, China
Country:
China
Website Url:
http://www.xellsmart.com
Status:
Active
Contact:
021-64027719
Email Addresses:
[email protected]
Total Funding:
77 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving Apache Mobile Non Scaleable Content Euro Microsoft Azure DNS Apple Mobile Web App Capable Pound Sterling Apple Mobile Web App Status Bar Style
Current Employees Featured
Founder
Investors List
Lilly Asia Ventures
Lilly Asia Ventures investment in Seed Round - XellSmart
Sequoia Capital China
Sequoia Capital China investment in Seed Round - XellSmart
Next Capital
Next Capital investment in Seed Round - XellSmart
Tao Capital Partners
Tao Capital Partners investment in Seed Round - XellSmart
Teda Venture Capital
Teda Venture Capital investment in Seed Round - XellSmart
Qiming Venture Partners
Qiming Venture Partners investment in Seed Round - XellSmart
FREES FUND
FREES FUND investment in Seed Round - XellSmart
Official Site Inspections
http://www.xellsmart.com Semrush global rank: 8.64 M Semrush visits lastest month: 274
- Host name: 106.15.55.34
- IP address: 106.15.55.34
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "XellSmart"
About_XellSmart biomedical (Suzhou) Co., Ltd
In 2021, Dr. Li Xiang took the lead in founding XellSmart, serving as the CEO and CSO. It united Dr. Xiao, Dr. Yan, Manager Qiu and brought together Dr. Chen, Dr. Huang, Dr. Zhu, and VP …See details»
XellSmart - Crunchbase Company Profile & Funding
Organization. XellSmart . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Xellsmart develops stem cell treatment …See details»
士泽生物医药（苏州）有限公司
邮箱：[email protected] 地址：上海市闵行区元江路金领谷科技产业园1号 楼601-607室 地址：江苏省苏州市工业园区生物医药产业园3期 B区3幢201室See details»
About_XellSmart biomedical (Suzhou) Co., Ltd
XellSmart is committed to providing large-scale, low-cost stem cell therapy solutions for a series of major diseases such as Parkinson's disease for which there is no clinical solution. Under …See details»
XellSmart Biomedical (Suzhou) Co., Ltd - Drug pipelines, Patents ...
May 1, 2024 Explore XellSmart Biomedical (Suzhou) Co., Ltd with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Endocrinology and …See details»
Xellsmart Company Profile 2024: Valuation, Funding & Investors
Xellsmart General Information Description. Developer of stem cell treatment solutions intended to improve major disease treatment and drug discovery. The company is committed to providing …See details»
Xellsmart - Products, Competitors, Financials, Employees, …
Xellsmart was founded in 2021. Where is Xellsmart's headquarters? Xellsmart's headquarters is located at Room 201, Building 3, Zone B, Phase 3, Suzhou. What is Xellsmart's latest funding …See details»
XellSmart - Funding, Financials, Valuation & Investors - Crunchbase
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Search Crunchbase. ... How much funding has this …See details»
XellSmart - CoBee Company Profile & Funding Rounds
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China. …See details»
XellSmart - Contacts, Employees, Board Members, Advisors
Organization. XellSmart . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. XellSmart has 1 …See details»
XellSmart biomedical (Suzhou) Co., Ltd
【First in Class】XellSmart iPSC-derived Drug granted ODD by FDA. In November 2023, XellSmart Biomedical (Suzhou) Co., Ltd. (XellSmart Bio)'s clinical-grade iPSC-derived subtype-specific neural precursor cell product to …See details»
XellSmart Raises $27.6 Million for Low-Cost Stem Cell Therapies
Nov 8, 2022 Shanghai XellSmart Biomedical closed a $27.6 million in Series A1 financing to develop low-cost stem cell therapies for major unmet needs including Parkinson's disease. …See details»
XellSmart Biomedical (Suzhou) Co., Ltd: Drug pipelines, Patents ...
Aug 2, 2023 Explore XellSmart Biomedical (Suzhou) Co., Ltd with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Neoplasms, …See details»
China’s XellSmart Raises ~USD28m Series A1 From Qiming …
Nov 8, 2022 An independent, non-profit organization, the association brings together 300+ firms—including institutional investors, fund managers, and industry advisors—who manage …See details»
XS-001 (Xellsmart) - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 XS-001 (Xellsmart), Initially developed by XellSmart Biomedical (Suzhou) Co., Ltd, Now, its global highest R&D status is IND Application, Therapeutic Areas: Nervous System …See details»
XellSmart - Tech Stack, Apps, Patents & Trademarks - Crunchbase
XellSmart is actively using 17 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible , Viewport Meta , and SPF . Website Tech Stack by BuiltWithSee details»
XS-004 (Xellsmart) - Drug Targets, Indications, Patents - Synapse
Literatures (Medical) associated with XS-004 (Xellsmart) 01 Oct 2023 · European journal of haematology Despite warnings, co-medication with proton pump inhibitors and dasatinib is …See details»
Our Science+Pipeline_XellSmart biomedical (Suzhou) Co., Ltd
At the same time, XellSmart welcomes interested hospitals, enterprises, and scientific research institutions to contact with our company. By strengthening R&D cooperation, we can build data …See details»
Xellsmart announced that it has received $28 million in funding …
Nov 7, 2022 Xellsmart announced that it has received $28 million in a round of funding co-led by new investors, China-Singapore Suzhou Industrial Park Development Group Co., Ltd., FIG, …See details»
Xiang Li - Crunchbase Person Profile
Xiang Li is the Chief Executive Officer & Chief Scientific Officer & Founder of XellSmart.See details»